MedTrace Logo

HIV Resistance and Treatment Strategies

NCT00581802 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 89

Last updated 2012-05-04

No results posted yet for this study

Summary

The purpose of this observational study is to characterize which immune system cells hide the latent reservoir of HIV by counting the number of latent HIV in different subsets of CD4 cells. Observations will also be made on other possible mechanisms of HIV persistence by looking at cellular factors such as APOBEC3 and drug transporters. The purpose of this study is to develop new strategies to reduce and possibly eliminate the latent reservoir in HIV infected adults.

Conditions

  • HIV Infections

Sponsors & Collaborators

  • Vanderbilt University School of Medicine

    collaborator OTHER

  • National Institute of Allergy and Infectious Diseases (NIAID)

    lead NIH

Principal Investigators

  • Richard T. D'Aquila, MD · Vanderbilt University

  • Carey K. Hwang, MD, PhD · Vanderbilt University

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-01-31
Completion
2011-01-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00581802 on ClinicalTrials.gov